Research Article
Multicomponent Therapeutics of Berberine Alkaloids
Table 1
Quadratic rotation-orthogonal combination design and results.
| No. | JAT | COP | BER | EPI | PAL | Inhibiting ratio (%) |
| 1 | 1 | 1 | 1 | 1 | 1 | 90.6 | 2 | 1 | 1 | 1 | −1 | −1 | 70.0 | 3 | 1 | 1 | −1 | 1 | −1 | 50.7 | 4 | 1 | 1 | −1 | −1 | 1 | 44.1 | 5 | 1 | −1 | 1 | 1 | −1 | 66.3 | 6 | 1 | −1 | 1 | −1 | 1 | 72.9 | 7 | 1 | −1 | −1 | 1 | 1 | 30.0 | 8 | 1 | −1 | −1 | −1 | −1 | 32.5 | 9 | −1 | 1 | 1 | 1 | −1 | 43.0 | 10 | −1 | 1 | 1 | −1 | 1 | 70.4 | 11 | −1 | 1 | −1 | 1 | 1 | 52.3 | 12 | −1 | 1 | −1 | −1 | −1 | 30.4 | 13 | −1 | −1 | 1 | 1 | 1 | 61.9 | 14 | −1 | −1 | 1 | −1 | −1 | 26.3 | 15 | −1 | −1 | −1 | 1 | −1 | 37.3 | 16 | −1 | −1 | −1 | −1 | 1 | 16.2 | 17 | −2 | 0 | 0 | 0 | 0 | 20.9 | 18 | 2 | 0 | 0 | 0 | 0 | 40.4 | 19 | 0 | −2 | 0 | 0 | 0 | 29.3 | 20 | 0 | 2 | 0 | 0 | 0 | 71.0 | 21 | 0 | 0 | −2 | 0 | 0 | 23.9 | 22 | 0 | 0 | 2 | 0 | 0 | 40.4 | 23 | 0 | 0 | 0 | −2 | 0 | 17.8 | 24 | 0 | 0 | 0 | 2 | 0 | 39.2 | 25 | 0 | 0 | 0 | 0 | −2 | 9.5 | 26 | 0 | 0 | 0 | 0 | 2 | 30.8 | 27 | 0 | 0 | 0 | 0 | 0 | 23.8 | 28 | 0 | 0 | 0 | 0 | 0 | 41.8 | 29 | 0 | 0 | 0 | 0 | 0 | 42.8 | 30 | 0 | 0 | 0 | 0 | 0 | 28.6 | 31 | 0 | 0 | 0 | 0 | 0 | 39.5 | 32 | 0 | 0 | 0 | 0 | 0 | 44.9 | 33 | 0 | 0 | 0 | 0 | 0 | 39.0 | 34 | 0 | 0 | 0 | 0 | 0 | 30.3 | 35 | 0 | 0 | 0 | 0 | 0 | 41.5 | 36 | 0 | 0 | 0 | 0 | 0 | 36.7 |
|
|